Ensign Peak Advisors Inc Boosts Holdings in Oscar Health, Inc. (NYSE:OSCR)

Ensign Peak Advisors Inc increased its position in Oscar Health, Inc. (NYSE:OSCR) by 10.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 43,022 shares of the company’s stock after purchasing an additional 4,100 shares during the quarter. Ensign Peak Advisors Inc’s holdings in Oscar Health were worth $578,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in OSCR. Tower Research Capital LLC TRC raised its stake in Oscar Health by 171.4% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company’s stock worth $89,000 after acquiring an additional 4,185 shares during the period. KBC Group NV lifted its position in shares of Oscar Health by 56.1% during the 4th quarter. KBC Group NV now owns 7,107 shares of the company’s stock valued at $96,000 after acquiring an additional 2,555 shares during the last quarter. Alberta Investment Management Corp purchased a new position in Oscar Health in the 4th quarter worth about $138,000. Virtu Financial LLC purchased a new position in shares of Oscar Health in the fourth quarter worth approximately $140,000. Finally, Potentia Wealth purchased a new stake in shares of Oscar Health in the fourth quarter valued at $141,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director now directly owns 64,512 shares of the company’s stock, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 24.39% of the stock is owned by corporate insiders.

Oscar Health Price Performance

Shares of OSCR opened at $17.52 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The stock’s 50-day moving average price is $13.46 and its two-hundred day moving average price is $14.66. The stock has a market cap of $4.39 billion, a P/E ratio of -875.31 and a beta of 1.75.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. During the same quarter in the prior year, the firm posted $0.62 EPS. The firm’s revenue for the quarter was up 42.2% compared to the same quarter last year. On average, equities analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Analyst Ratings Changes

Separately, Wells Fargo & Company cut Oscar Health from an “overweight” rating to an “equal weight” rating and reduced their price objective for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, two have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $20.08.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.